/Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4)
Abstract
The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGFβ superfamily protein.
Full Text
What is claimed is:
The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGFβ superfamily protein.
Timeline
Filed
03/06/2026Published
07/09/2026Granted
Not AvailableIPC Codes(7)
C07K 16/26:against hormones
A61K 38/10:Peptides having 12 to 20 amino acids
A61K 39/00:Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53)